Dialog window
×
Home
Solutions
  • Digital Products
  • Medical-Grade AI™
  • Enterprise Platform
  • PDURS
  • EHR Solutions
About Us
News
Careers
Contact us
  • Solutions
    • Digital Products
    • Medical-Grade AI™
    • Enterprise Platform
    • PDURS
    • EHR Solutions
  • About Us
  • News
  • Careers
Contact us
a
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

by Fred Galik | Mar 3, 2026 | Featured, News

March 03, 2026, WILMINGTON, DE (BUSINESS WIRE) – Amalgam Rx, Inc., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ: PRVA)-led colorectal cancer (CRC) screening program,...
Amalgam Rx’s Medical-Grade AI™️ Doubles Digital Health Engagement—Validated in Peer-Reviewed Studies

Amalgam Rx’s Medical-Grade AI™️ Doubles Digital Health Engagement—Validated in Peer-Reviewed Studies

by Fred Galik | Oct 20, 2025 | News

WILMINGTON, DE — (BUSINESS WIRE) — Amalgam Rx, Inc., a leader in AI-powered healthcare decision-making, announced the publication of two peer-reviewed research papers validating its Medical‑Grade AI™ technology—a clinically governed system delivering...
Amalgam Rx Partners with Biolinq — Lighting Pathways to Better Health

Amalgam Rx Partners with Biolinq — Lighting Pathways to Better Health

by Fred Galik | Oct 16, 2025 | News

WILMINGTON, DE — (BUSINESS WIRE) — Amalgam Rx, Inc., a leading provider of software for regulated medical devices, powered by their Medical-Grade Al™ technology, announced its collaboration with Biolinq Incorporated in developing the digital backbone for...
Amalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Medical-Grade AI™️ Deployment

Amalgam Rx Secures $20M Credit Investment from Catalio Capital Management to Accelerate Medical-Grade AI™️ Deployment

by Fred Galik | Aug 12, 2025 | News

WILMINGTON, DE — (BUSINESS WIRE) — Amalgam Rx, Inc., a leader in enabling data-driven healthcare decision making, today announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative...
Amalgam Rx and Otsuka Precision Health, Inc (OPH) Announce AI Digital Support Solution for Caregivers of Patients with Alzheimer’s Disease

Amalgam Rx and Otsuka Precision Health, Inc (OPH) Announce AI Digital Support Solution for Caregivers of Patients with Alzheimer’s Disease

by Fred Galik | Oct 7, 2024 | News

PRINCETON, N.J. and WILMINGTON, DE — (BUSINESS WIRE) — Otsuka Precision Health, Inc., (OPH), and Amalgam Rx, Inc., (Amalgam) announce the launch of ElevmiTM – an intelligent digital application that helps caregivers support loved ones with Alzheimer’s...
Amalgam’s Medical-Grade AI™️ Wins Coveted 2024 AI Breakthrough Awards

Amalgam’s Medical-Grade AI™️ Wins Coveted 2024 AI Breakthrough Awards

by Fred Galik | Jun 26, 2024 | News

LOS ANGELES, Calif., June 26, 2024 – AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market, today announced that Amalgam Rx, Inc., a leader in enabling...
« Older Entries

Popular Posts

Ready to reimagine healthcare?

Let us know how we can help. Get the conversation started today.

  • New Project
  • Join Our Team
  • General Inquiries

What is your name?(Required)

"(Required)" indicates required fields

What is your name?(Required)
Max. file size: 50 MB.

"(Required)" indicates required fields

What is your name?(Required)
  • Digital Products
  • Medical-Grade AI™
  • Enterprise Platform
  • PDURS
  • EHR Solutions
  • About Us
  • News
  • Careers
LinkedIn

Privacy Policy

© 2026 Amalgam Rx, Inc.

  • Digital Products
  • Medical-Grade AI™
  • Enterprise Platform
  • PDURS
  • EHR Solutions
  • About Us
  • News
  • Careers
LinkedIn

Privacy Policy

© 2026 Amalgam Rx, Inc.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}